Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Glycosylation-related genes mediated prognostic signature contribute to prognostic prediction and treatment options in ovarian cancer: based on bulk and single‑cell RNA sequencing data

Fig. 3

Construction and validation of a GRGs signature. (A) Univariate analysis selected genes with significant prognostic value from the GRGs. (B) LASSO Cox regression analysis was performed to select genes to conduct a GRGs signature. (C) Coefficients of 16 genes in GRGs signature. (D) Kaplan-Meier prognostic analysis in TCGA dataset. (E) The AUC values at 1, 2, 3, 4, and 5 years for TCGA dataset. (F) Calibration curves of 1-, 3-, 5-year in TCGA dataset. (G) Kaplan-Meier prognostic analysis in GSE63885 dataset. (H) The AUC values at 1, 2, 3, 4, and 5 years for GSE63885 dataset. (I) Calibration curves of 1-, 3-, 5-year in GSE63885 dataset. (J) Kaplan-Meier prognostic analysis in clinical samples. (K) The AUC values at 1, 2, 3, 4, and 5 years for clinical samples. (L) Calibration curves of 1-, 3-, 5-year in clinical samples

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us